More News

GATC Health and UC Irvine publication validates AI-platform for opioid use disorder treatment

Jim Cornall -
GATC Health Corp and researchers from the University of California, Irvine (UCI) have published a joint study in the...

Gilead to acquire Tubulis

Jim Cornall -
Gilead Sciences, Inc. has entered into a definitive agreement to acquire Tubulis GmbH, a private clinical-stage biotechnology company developing...

Fast Track Designation for T-cell therapy enhanced with membrane-tethered IL-12 booster

Jim Cornall -
A2 Biotherapeutics, Inc. (A2 Bio) has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track...

Walks to support Lennox-Gastaut syndrome research

Jim Cornall -
The Lennox-Gastaut Syndrome (LGS) Foundation is mobilising Walks for LGS Research around the US this month. The event unites...

Precision nanomedicine to target most challenging tumours

Jim Cornall -
Eascra Biotech is leveraging the International Space Station (ISS) National Laboratory to advance the next generation of targeted cancer...

Base to Base biotech podcast 54: Parkinson’s disease and peptides

Jim Cornall -
This week, because April 11 is World Parkinson’s Day, we chat with Dieter Willbold, CSO of Priavoid, and Antje...

Study shows prostate cancer can be detected through urine-based liquid biopsy

Jim Cornall -
PanGIA Biotech, Inc. has announced a peer-reviewed clinical study published in Diagnostics, "Urine-Based Machine Learning Assay Detects Prostate Cancer,"...

Cyclerion and Korsana announce merger

Jim Cornall -
Cyclerion Therapeutics, Inc. and Korsana Biosciences, Inc. have entered into a definitive merger agreement for an all-stock transaction. Upon...

“Groundbreaking” data for Charcot-Marie-Tooth disease type 1A treatment

Jim Cornall -
Armatus Bio has announced the publication of foundational data in Molecular Therapy Nucleic Acids describing the safety and biodistribution...

Positive results from moderate-to-severe atopic dermatitis trial

Jim Cornall -
Enveda has announced positive phase 1b results for ENV-294, a first-in-class, oral, once-daily investigational therapy, in patients with moderate-to-severe...

Centessa Pharmaceuticals to be acquired by Lilly

Jim Cornall -
Nxera Pharma Co., Ltd.’s partner, Centessa Pharmaceuticals Limited, has entered into a definitive agreement regarding its acquisition by Eli...

Smart drugs to fight cancer

Jim Cornall -
How cancer cells can be targeted without damaging healthy tissue is one of the major challenges facing oncology today....

OpenProtein.AI expands partnership with Boehringer Ingelheim on AI-driven antibody discovery

Jim Cornall -
OpenProtein.AI has announced an expansion of its partnership with Boehringer Ingelheim to co-develop specialised antibody discovery and optimisation workflows....

New biomarker helps assess aggression of glioblastoma

Jim Cornall -
Researchers from the Biomedical Data Science Laboratory (BDSLab) at the ITACA Institute of the Universitat Politècnica de València in...

Protein helps cancer cells survive treatment

Jim Cornall -
Researchers at Umeå University in Sweden have contributed new insights into how cancer cells protect themselves from cell death....

Base to Base biotech podcast 53: Diagnosing autism and improving transplant outcomes

Jim Cornall -
On this week’s episode, as April 2 is World Autism Day, we have a conversation with Manish Arora, CEO...

IND approval for bispecific ADC

Jim Cornall -
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. has announced that the Investigational New Drug (IND) application for SKB103, its self-developed novel...

World’s largest clinically linked spatial biology atlas launched

Jim Cornall -
Bioptimus has announced the launch of its Spatial Tissue Embedding Learning Atlas (STELA), a multinational spatial data generation initiative...

Changing the search for rare disease diagnoses with AI breakthrough

Jim Cornall -
A newly developed AI tool can speed up the search for the genetic causes of rare diseases, a process...

Precision medicine helps more patients receive genetic diagnosis

Jim Cornall -
A collaboration between Karolinska Institutet, Karolinska University Hospital, and SciLifeLab has integrated whole genome sequencing into routine diagnostic investigations...

Tumour DNA in blood after pre-surgery treatments predicts if breast cancer will return

Jim Cornall -
Fragments of tumour DNA in the bloodstream of patients with breast cancer can predict whether they are likely to...